ASN
ACOR

Advisory Services Network’s Acorda Therapeutics ACOR Stock Holding History

Advisory Services Network’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-333
Closed -$307K – 3306
2019
Q3 		$307K Hold
333
– – 0.02% 687
2019
Q2 		$307K Buy
333
+29
+10% +$35.6K 0.02% 685
2019
Q1 		$485K Buy
304
+201
+195% +$362K 0.03% 530
2018
Q4 		$193K Sell
103
-52
-34% -$113K 0.02% 712
2018
Q3 		$365K Buy
+155
New +$480K 0.03% 594

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Advisory Services Network's ACOR Position: Q4 2019 in Review

Advisory Services Network sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 333 shares — an estimated $307K sold.

Advisory Services Network first reported a position in ACOR in Q3 2018 and held it in 5 quarters. The position peaked at $485K in Q1 2019. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Advisory Services Network reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Advisory Services Network sold 333 Acorda Therapeutics shares in Q4 2019, an estimated $307K.
  • Advisory Services Network first reported a position in Acorda Therapeutics in Q3 2018 and held it in 5 quarters.
  • Advisory Services Network's Acorda Therapeutics position peaked at $485K in Q1 2019.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Advisory Services Network's 13F filing for Q4 2019, filed 4 Feb 2020.